Shares of Zevia plunged 15% following earnings as investors reacted negatively to signs of deceleration in execution and a cautious outlook, despite hitting sales guidance. The market penalized the company's acknowledgment of underwhelming in-store execution and the need for urgent improvement in distribution and brand activation.
Zevia PBC reported a strong Q3 2025, with net sales up 12% year-over-year to $40.8 million, driven by successful brand marketing and innovative product launches, leading to an upward revision of sales and EBITDA guidance.